Occlutech International AB
Location
Skåne
Founded
2007-01-23
Website
Risk Signals
43 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Equipment, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Occlutech International AB
Live alerts from global media, monitored by Business Radar
2024-06-12 (ihk.de)
“I can’t work like this” – DIHK campaign shows problems in the economy
June 11, 2024: Too often in the past, announcements of relief have not been followed by concrete implementation steps. Quite the opposite: companies are being overwhelmed by more and more restrictions, restrictions and regulations.
Read more
2023-03-14 (medicaldevice-network.com)
Occlutech begins subject enrolment in Atrial Flow Regulator trial
Minimally invasive cardiac devices provider Occlutech has enrolled the first participant in the FROST-HF study of its Atrial Flow Regulator.
Read more
2020-12-31 (pulmonaryhypertensionnews.com)
Atrial Flow Regulator Receives FDA’s Breakthrough Device Designation
Occlutech’s atrial flow regulator (AFR) received the breakthrough device designation by the U.S. Food and Drug Administration for the treatment of pulmonary arterial hypertension.
Read more
2020-12-21 (medicaldevice-network.com)
US FDA grants Breakthrough Device Designation to Occlutech’s Atrial Flow Regulator
The US FDA granted Occlutech a Breakthrough Device designation for Occlutech’s implantable Atrial Flow Regulator (AFR) for PAH.
Read more